Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neurotoxicology|November 14, 2002
Parkinson's genetics: molecular insights for the new millenniumLisa Skipper, Matt Farrer
Expert Opinion on Pharmacotherapy|April 26, 2006
Polymorphisms in candidate genes: implications for the current treatment of Parkinson's diseaseLisa Skipper, Jian-Jun Liu, Eng-King Tan
Movement Disorders : Official Journal of the Movement Disorder Society|November 4, 2006
LRRK2 G2019S founder haplotype in the Chinese populationEng-King Tan, Lisa Skipper, Louis Tan, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|September 10, 2004
Identification of the human ubiquitin specific protease 31 (USP31) gene: structure, sequence and expression analysisPaul J Lockhart, Mary Hulihan, Sarah Lincoln, et al.
Neuroscience Letters|April 18, 2002
The tau H1 haplotype is associated with Parkinson's disease in the Norwegian populationMatt Farrer, Lisa Skipper, Marianne Berg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 8, 2006
Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's diseaseE K Tan, Lisa Skipper, Eva Chua, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2004
Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutationsJoseph Wiley, Timothy Lynch, Sarah Lincoln, et al.
American Journal of Human Genetics|August 7, 2004
Linkage disequilibrium and association of MAPT H1 in Parkinson diseaseLisa Skipper, Kristen Wilkes, Mathias Toft, et al.
Human Molecular Genetics|November 5, 2005
Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's diseaseLisa Skipper, Yi Li, Carine Bonnard, et al.
Annals of Neurology|September 30, 2004
alpha-Synuclein promoter confers susceptibility to Parkinson's diseasePhilippe Pals, Sarah Lincoln, Jonathan Manning, et al.
Pageof 2